Knut B Bjorklund

Title: Innovations by Knut B Bjorklund

Introduction

Knut B Bjorklund is a notable inventor based in Bromma, Sweden. He has made significant contributions to the field of cancer research through his innovative patents. With a total of 3 patents, his work focuses on cancer-associated polypeptide antigens and their applications in diagnostics and immunization.

Latest Patents

Knut B Bjorklund's latest patents include several groundbreaking inventions. One patent details a process for the isolation of cancer-associated polypeptide antigens, primarily utilizing gel filtration and pH-gradient elution. Another patent describes a cancer-associated polypeptide antigen based on a single peptide chain that denatures irreversibly at pHs exceeding about 4.5. Additionally, he has developed a composition that includes such antigens mixed with a stabilizing amount of albumen. His work also encompasses a diagnostic composition featuring a particulate material labeled with albumen-stabilized antigens. Furthermore, he has devised a method for preparing antibodies that are monospecific to the cancer-associated polypeptide antigen, which involves creating an oil emulsion that encloses an acid aqueous solution of the polypeptide. Lastly, he has contributed to a cancer diagnosis method that determines the presence of cancer-associated polypeptide antigens in living animal bodies.

Career Highlights

Throughout his career, Knut B Bjorklund has worked with various organizations, enhancing his expertise in the field. Notably, he has been associated with Ab Bonnierforetagen, where he has furthered his research and development efforts.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Knut B Bjorklund's innovative work in cancer research has led to significant advancements in the understanding and diagnosis of cancer-associated polypeptide antigens. His contributions continue to impact the field positively.